Radiotherapy in the management of lung oligometastases

被引：0

作者：

Bourbonne, V. ^{[1
,2
]}

Levy, A. ^{[3
,4
]}

Khalifa, J. ^{[5
]}

Antoni, D. ^{[6
]}

Blais, E. ^{[7
]}

Darreon, J. ^{[8
]}

Le Pechoux, C. ^{[3
,4
]}

Lerouge, D. ^{[9
]}

Giraud, P. ^{[10
,11
]}

Marguerit, A. ^{[12
]}

Pourel, N. ^{[13
]}

Riet, F. -g. ^{[14
]}

Thureau, S. ^{[15
,16
]}

机构：

[1] CHU Brest, Radiat Oncol Dept, Brest, France

[2] Univ Bretagne Occidentale, LaTim, Inserm, UMR 1101, Brest, France

[3] Ctr Int Canc Thorac CICT, Dept Radiat Oncol, Gustave Roussy, F-94805 Villejuif, France

[4] Univ Paris Saclay, Fac Med, F-94270 Le Kremlin Bicetre, France

[5] Inst Claudius Regaud, Inst Univ Canc Toulouse Oncopole, Dept Radiat Oncol, Toulouse, France

[6] Inst Cancerol Strasbourg Europe, Inst Claudius Regaud, Toulouse, France

[7] Inst Cancerol Strasbourg Europe, Dept Radiat Oncol, Strasbourg, France

[8] Polyclin Marzet, Dept Radiat Oncol, Pau, France

[9] Ctr Francois Baclesse, Dept Radiat Oncol, Caen, France

[10] Hop Europeen Georges Pompidou, Ctr Francois Baclesse, Paris, France

[11] Univ Paris Cite, Paris, France

[12] Inst Cancerol Montpellier, Paris, France

[13] Inst St Catherine, Dept Radiat Oncol, Avignon, France

[14] Ctr Hosp Pr St Gregoire, Dept Radiat Oncol, F-35760 St Gregoire, France

[15] Ctr Henri Becquerel, Radiotherapy Dept, Rouen, France

[16] Univ Rouen, QuantIF Litis EA4108, Rouen, France

来源：

CANCER RADIOTHERAPIE | 2024年 / 28卷 / 01期

关键词：

Oligometastasis; Lung; Surgery; Stereotactic radiotherapy; STEREOTACTIC-BODY-RADIOTHERAPY; ABLATIVE RADIATION-THERAPY; LOCATED EARLY-STAGE; QUALITY-OF-LIFE; PHASE-II; COLORECTAL-CANCER; PULMONARY OLIGOMETASTASES; MULTICENTER PHASE-2; PROGNOSTIC-FACTORS; DOSE-ESCALATION;

D O I：

10.1016/j.canrad.2023.06.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years, the development of both medical imaging and new systemic agents (targeted therapy and immunotherapy) have revolutionized the field of oncology, leading to a new entity: oligometastatic disease. Adding local treatment of oligometastases to systemic treatment could lead to prolonged survival with no significant impact on quality of life. Given the high prevalence of lung oligometastases and the new systemic agents coming with increased pulmonary toxicity, this article provides a comprehensive review of the current state-of-art for radiotherapy of lung oligometastases. After reviewing pretreatment workup, the authors define several radiotherapy regimen based on the localization and size of the oligometastases. A comment on the synergistic combination of medical treatment and radiotherapy is also made, projecting on future steps in this specific clinical setting. (c) 2023 Socie ' te ' franc, aise de radiothe ' rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：36 / 48

页数：13

共 50 条

[41] Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer
Li, Shuai
Dong, Dezuo
Geng, Jianhao
Zhu, Xianggao
Shi, Chen
Zhang, Yangzi
Wang, Hongzhi
Zhou, Shun
Wu, Hao
Cai, Yong
Li, Yongheng
Wang, Weihu
FRONTIERS IN ONCOLOGY, 2019, 9
[42] SURGERY FOR EARLY STAGE LUNG CANCER AND OLIGOMETASTASES
Asamura, Hisao
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S83 - S84
[43] Whole-Brain Radiotherapy Combined with Surgery or Stereotactic Radiotherapy in Patients with Brain Oligometastases
D'Agostino, Giuseppe Roberto
Autorino, Rosa
Pompucci, Angelo
De Santis, Maria Carmen
Manfrida, Stefania
Di Lella, Giuseppe
Mantini, Giovanna
Frascino, Vincenzo
Chiesa, Silvia
Albanese, Alessio
Dinapoli, Nicola
Azario, Luigi
Fiorentino, Alba
Valentini, Vincenzo
Anile, Carmelo
Balducci, Mario
STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (07) : 421 - 425
[44] Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy
Klement, R. J.
Hoerner-Rieber, J.
Adebahr, S.
Andratschke, N.
Blanck, O.
Boda-Heggemann, J.
Duma, M.
Eble, M. J.
Eich, H. C.
Flentje, M.
Gerum, S.
Hass, P.
Henkenberens, C.
Hildebrandt, G.
Imhoff, D.
Kahl, K. H.
Klass, N. D.
Krempien, R.
Lohaus, F.
Petersen, C.
Schrade, E.
Wendt, T. G.
Wittig, A.
Guckenberger, M.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 (02) : 246 - 252
[45] Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors
Cuccia, Francesco
Mazzola, Rosario
Figlia, Vanessa
Giaj-Levra, Niccolo
Nicosia, Luca
Ricchetti, Francesco
Rigo, Michele
Attina, Giorgio
Vitale, Claudio
Pastorello, Edoardo
Ruggieri, Ruggero
Alongi, Filippo
STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (10) : 934 - 939
[46] A rationale for the targeted treatment of oligometastases with radiotherapy
MacDermed, Dhara M.
Weichselbaum, Ralph R.
Salama, Joseph K.
JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (03) : 202 - 206
[47] A multinational report of technical factors on stereotactic body radiotherapy for oligometastases
Redmond, Kristin J.
Lo, Simon S.
Dagan, Roi
Poon, Ian
Foote, Matthew C.
Erler, Darby
Lee, Young
Lohr, Frank
Biswas, Tithi
Ricardi, Umberto
Sahgal, Arjun
FUTURE ONCOLOGY, 2017, 13 (12) : 1081 - 1089
[48] MR-guided online adaptive stereotactic body radiotherapy (MRgSBRT) of primary lung tumors and lung oligometastases
Ugurluer, Gamze
Dincer, Neris
Mustafayev, Teuta Zoto
Gungor, Gorkem
Abacioglu, Mehmet Ufuk
Sengoz, Meric
Ozyar, Enis
Atalar, Banu
STRAHLENTHERAPIE UND ONKOLOGIE, 2024, : 637 - 644
[49] Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
Jingu, Keiichi
Matsushita, Haruo
Yamamoto, Takaya
Umezawa, Rei
Ishikawa, Yojiro
Takahashi, Noriyoshi
Katagiri, Yu
Takeda, Kazuya
Kadoya, Noriyuki
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
[50] Emerging Role of Radiotherapy in the Management of Liver Metastases
Swaminath, Anand
Dawson, Laura A.
CANCER JOURNAL, 2010, 16 (02) : 150 - 155

← 1 2 3 4 5 →